Article Listing - Bayer expects EU launch of new long-term contraceptive system Jaydess in 2nd-qtr 2013

HUNGARIAN DRUGS "STILL COMPETITIVE"

6 April 1992

Despite the collapse of the Soviet market, Hungarian pharmaceutical companies have succeeded in making up for these lost sales by...

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

New sales and earnings records were achieved in 1991 by American Home Products (Mar-ketletter January 20). The year was said...

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

Despite the enormous size of some Continental European pharmaceutical companies, they are being valued by their respective equity capital markets...

BLOOD BANKING AND PLASMA PRODUCTS

6 April 1992

The world market for blood banking and plasma products was valued at $2.5 billion in 1990, and is expected to...

AUSTRALIAN VACCINE RESEARCH

6 April 1992

The Walter and Eliza Hall Institute of Medical research in Melbourne, Australia, is to set up a commercial joint venture...

MGI PHARMA'S SALAGEN

6 April 1992

MGI Pharma has gained orphan drug status from the US Food and Drug Administration for Salagen (pilocarpine), to treat dry...

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

Italian Raw Materials Sales

6 April 1992

The Italian pharmaceutical raw materials market expanded by 8% in 1991 to 2,500 billion lire ($2.1 billion), according to the...

GERMAN COMPANIES REACT TO BKA WARNING

6 April 1992

Two leading German drug wholesalers, Gehe of Stuttgart and Sanacorp of Bavaria, have reacted sharply to the recent warning by...

SANOFI 1991 NET INCOME UP 12.1%

6 April 1992

For France's Elf Sanofi, earnings progressed satisfactorily in 1991 despite the adverse operating environment (the world economic situation including the...

Showing 94371-94380 of 95325 articles